No abstract

This study compared the values and reliability of peak running speeds from incremental treadmill protocols with different speed increments. Thirty-one men, recreational, endurance-trained runners performed, in an alternate order, three continuous tests with different speed increments (0.5, 1 and 2 km · h(-1)). The tests were repeated using the same order. Peak speed was identified as (1) the greatest speed that could be maintained for a complete minute (Vpeak-60s), (2) the speed of the last complete stage (Vpeak-C) and (3) the speed of the last complete stage added to the product of the speed increment and the completed fraction of the incomplete stage (Vpeak-P). The Vpeak-P was the most reliable, independent of the incremental test protocol (1.5% ≤ CV ≤ 1.8%), and differently from Vpeak-C (1.8% ≤ CV ≤ 2.6%) and Vpeak-60s (1.6% ≤ CV ≤ 3.8%), the Vpeak-P was only slightly influenced by the incremental test protocol. The results suggest that Vpeak-P should be used to assess aerobic capability and monitor training effects and that other determinations of peak speed should be avoided.

This study aimed to investigate the influence of endurance running training associated with PBM on endurance performance variables and muscle soreness in untrained men. Thirty untrained men were distributed randomly into a placebo (PLA) group and photobiomodulation group (PBMG) and they performed 8 weeks of running training. The PBMG had the PBM performed before all training sessions. The PBM was applied using LED equipment with 56 diodes of red light (660 nm) and 48 diodes of infrared light (850 nm). The application was performed in 5 points per leg, with a dose of 60 J at each point and a total energy delivered per leg of 300 J. Peak running velocity, time limit tests and 5-km performance were assessed pre and post-training; muscle soreness was evaluated before all training sessions. The Vpeak increased and 5-km running time (t5–km) decreased (P < 0.001) in both groups. In addition, the magnitude based-inference analysis showed a possibly positive effect on Vpeak and t5–km and for PBMG compared to PLA group. Furthermore, there was a moderate ES of 0.82 on attenuation in muscle soreness in the third week of endurance running training. Therefore, although the magnitude-based inference analysis demonstrated a possibly positive effect on Vpeak and t5–km and for PBMG compared to PLA group and a moderate ES on attenuation in muscle soreness in the last weeks of endurance running training, no significant difference were found between PBMG and PLA interventions.

No abstract

The present study examined whether the running speed at the lactate threshold estimated by the maximal deviation method (LT (Dmax)) is highly correlated and in agreement with 10-km road race performance (S (10 km)) in middle-aged female runners. Additionally, the LT (Dmax) was compared with the visual detection of the inflection point (LT (Visual)), the fixed lactate level of 4 mmol.L (-1) (LT (4)) and the peak speed (S (peak)) in relation to performance. Sixteen middle-aged, recreational female runners performed a discontinuous, incremental treadmill test. The initial speed was set at 7 km.h (-1), and this speed was increased every 3 min by 1 km.h (-1) with a 30-s rest between the stages used for earlobe capillary blood sample collection. All of the participants took part in the same local 10-km road race, and S (10 km) mean speed was calculated. The speeds (mean ± SD) were 10.5 ± 1.0 (S (10 km)), 10.5 ± 1.0 (LT (Visual)), 10.9 ± 0.9 (LT (Dmax)), 11.4 ± 1.3 (LT (4)) and 13.5 ± 1.1 km.h (-1) (S (peak)). The LT (Dmax) had the narrowest limits of agreement (0.3 ± 0.4 km.h (-1)) and was the most highly correlated with the S (10 km) ( R=0.98), followed by the S (peak) ( R=0.95), LT (4) ( R=0.85) and LT (Visual) ( R=0.81). In conclusion, the LT (Dmax) should be more widely used to estimate long-distance performance and to verify improvements in training.